alpha-Mer590 mAb (University of Colorado)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namealpha-Mer590 mAb (University of Colorado)
Drug Alias Namemer receptor tyrosine kinase inhibitor (University of Colorado)alpha-Mer590 mAb (University of Colorado System)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTyrosine-protein kinase Mer inhibitorsCoagulation factor inhibitors
TargetsCoagulation factorTyrosine-protein kinase Mer
Therapy Area/IndicationsThrombosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Colorado System
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Colorado SystemUniversity Of Colorado
Active IndicationsN/A
Inactive IndicationsThrombosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A